MED
Medifast
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 1
Sell signal 2
Revenue Beats Expectation
Price Hits 52-week low
EPS Below Expectations
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About MED
Medifast, Inc.
A manufacturer of weight and disease management products and other health and diet products
Healthcare Providers and Services
Invalid Date
08/25/2006
New York Stock Exchange
504
12-31
Common stock
100 International Drive, Baltimore, Maryland 21202
--
Medifast, Inc., was incorporated in Delaware in 1989. The Company operates primarily through five wholly owned subsidiaries, Jason Pharmaceuticals Inc., Take Shape For Life Inc., Jason Enterprises Inc., Jason Properties LLC and Seven Crondall LLC. Its business is the production, distribution and sale of weight management and disease management products and other health and dietary consumables. Its product line includes weight and disease management, meal substitutes and vitamins, which are primarily produced at an FDA-approved modern factory in Owings, Maryland.
Company Financials
EPS
MED has released its 2025 Q1 earnings. EPS was reported at -0.03, versus the expected -0.25, beating expectations. The chart below visualizes how MED has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
MED has released its 2024 Q4 earnings report, with revenue of 119.00M, reflecting a YoY change of -37.70%, and net profit of 801.00K, showing a YoY change of -86.73%. The Sankey diagram below clearly presents MED’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
